New study tracks Real-Life use of TGCT drug vimseltinib
NCT ID NCT07075471
First seen Nov 06, 2025 · Last updated May 08, 2026 · Updated 22 times
Summary
This study watches how people with tenosynovial giant cell tumor (TGCT) use vimseltinib in real-world settings. Researchers will track treatment patterns and quality of life without changing standard care. About 100 participants will join, and the study does not test new treatments or assign medications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TENOSYNOVIAL GIANT CELL TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Synexus Clinical Research, US INC
RECRUITINGWilmington, North Carolina, 28401, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.